Tim Philippi – Executive Director, Singaporean-German Chamber of Industry & Commerce (SGC)

26.01.2021
The SGC's Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences within it. Dr Philippi also outlines the impact of the COVID-19 pandemic on the SGC's members and why Singapore remains the premier investment destination for European companies in Asia.  
Some of the advantages [of Singapore] include an excellent educated workforce, the English language, a reliable legal system, and the absence of corruption, to name just a few
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Singapore, SGC, Germany, Trade, Association, Chamber of Commerce

Related Interviews

Subra Suresh – President, Nanyang Technological University (NTU),…

Professor Subra Suresh, president of Nanyang Technological University (NTU) and former director of the US National Science Foundation, explains how the university has managed to consistently be among the top…

Ashish Mahajan – Partner, Deloitte Life Sciences & Healthcare…

Ashish Mahajan, Partner in Deloitte’s Life Sciences and Healthcare Consulting Practice in Southeast Asia, outlines some of the key trends playing out in the region, the extent to which the…

Angeline Ho – Communication & Patient Advocacy Lead, Oncology Cell…

Angeline Ho gives an overview of the patient advocacy landscape in Asia-Pacific, why an Asian model of patient engagement – distinct from those in Europe and the US – needs…

Related Articles

ASEAN / Key Features of Orphan Drug Registration in Singapore, Malaysia, Philippines, and Vietnam

Writing in the December edition of DIA’s Global Forum magazine, Agnes Ho, Cindy Zen, and Tan Kwee Lan of Boehringer Ingelheim give an overview of the current regulatory framework for…

APAC / Biotech Experts Talk Regulation, Infrastructure, Funding & Talent Gaps

Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by 2025, biotech-led clinical…

Global / 3 Pfizer Country Managers on COVID-19 Vaccine Rollout & Learnings

The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…

Latest Report

Singapore Pharma Report 2021

Related Content

Singapore
SGC
Germany
Trade
Association
Chamber of Commerce